Overview

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

Status:
Not yet recruiting
Trial end date:
2024-05-14
Target enrollment:
Participant gender:
Summary
This study will look how well semaglutide tablets taken once daily helps people with body weight above the healthy range. Participants will either get semaglutide 25 milligram (mg) once daily or placebo once daily. This study will last for 72 weeks, which includes 1-week screening period, 64 weeks of treatment period and 7 weeks of follow up period.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S